Skip to Main Content

“In the Know” features conversations with the people and personalities in biopharma.

Camille Samuels is one of just a smattering of female biopharma venture capitalists. But she doesn’t get too hung up on that fact: As a partner at Palo Alto’s Venrock and self-professed “math and science geek,” she prefers to focus solely on forging companies and making deals.

Unlock this article by subscribing to STAT+ and enjoy your first 30 days free!